{"id":"W3018861031","doi":"10.1136/bmjopen-2019-035959","title":"[ <sup>18</sup> F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial","year":2020,"lang":"en","type":"article","venue":"BMJ Open","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; McMaster University; Women's College Hospital; Centre for Probe Development and Commercialization; University of Toronto; University Health Network; Health Sciences Centre; Mount Sinai Hospital","funders":"Astellas Pharma; Terry Fox Research Institute; University of Toronto; Association of Canadian Universities for Research in Astronomy; Princess Margaret Cancer Foundation; Canadian Association of Radiation Oncology","keywords":"Medicine; Ablative case; Prostate cancer; Protocol (science); Clinical trial; Medical physics; Nuclear medicine; Radiation therapy; Cancer; Radiology; Internal medicine; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007452689,0.003231784,0.00297934,0.0006345928,0.001192121,0.001920527,0.002932494,0.003533822,0.01443427],"category_scores_gemma":[0.003676465,0.001623132,0.001356833,0.0009756837,0.002523162,0.001439,0.001112661,0.00473507,0.005628439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001874568,"about_ca_system_score_gemma":0.007073638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001290023,"about_ca_topic_score_gemma":0.00236349,"domain_scores_codex":[0.9971949,0.001383221,0.0001568978,0.0003937192,0.0002766112,0.0005946177],"domain_scores_gemma":[0.9975604,0.0002921762,0.000432345,0.0003292651,0.0003018131,0.001083927],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8624464,0.06618811,0.002289392,0.001650877,0.0006757082,0.0003124361,0.0002323653,0.003032519,0.02760539,0.0007562473,0.007896632,0.02691386],"study_design_scores_gemma":[0.7513182,0.2290789,0.002562384,0.00009928224,0.0003620303,0.0001252281,0.00006137566,0.0007834194,0.00461783,0.0005884141,0.01035478,0.00004816641],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.2637798,0.002010107,0.007375827,0.001437098,0.0006348868,0.7098827,0.00661808,0.0003771796,0.007884333],"genre_scores_gemma":[0.1876234,0.0017907,0.01207903,0.002585517,0.0003166302,0.7841013,0.004489944,0.000100909,0.006912618],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.01443427,"threshold_uncertainty_score":0.04828745,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2868840061302836,"score_gpt":0.5378987947938053,"score_spread":0.2510147886635217,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}